These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
5. IFN-γ or IFN-α ameliorates chronic proliferative dermatitis by inducing expression of linear ubiquitin chain assembly complex. Tamiya H; Terao M; Takiuchi T; Nakahara M; Sasaki Y; Katayama I; Yoshikawa H; Iwai K J Immunol; 2014 Apr; 192(8):3793-804. PubMed ID: 24634492 [TBL] [Abstract][Full Text] [Related]
6. Chronic proliferative dermatitis in Sharpin null mice: development of an autoinflammatory disease in the absence of B and T lymphocytes and IL4/IL13 signaling. Potter CS; Wang Z; Silva KA; Kennedy VE; Stearns TM; Burzenski L; Shultz LD; Hogenesch H; Sundberg JP PLoS One; 2014; 9(1):e85666. PubMed ID: 24465642 [TBL] [Abstract][Full Text] [Related]
7. Anti-IL5 decreases the number of eosinophils but not the severity of dermatitis in Sharpin-deficient mice. Renninger ML; Seymour RE; Whiteley LO; Sundberg JP; Hogenesch H Exp Dermatol; 2010 Mar; 19(3):252-8. PubMed ID: 19650867 [TBL] [Abstract][Full Text] [Related]
8. Distinct role of IL-1β in instigating disease in Sharpin Gurung P; Sharma BR; Kanneganti TD Sci Rep; 2016 Nov; 6():36634. PubMed ID: 27892465 [TBL] [Abstract][Full Text] [Related]
9. Sharpin Controls Osteogenic Differentiation of Mesenchymal Bone Marrow Cells. Jeschke A; Catala-Lehnen P; Sieber S; Bickert T; Schweizer M; Koehne T; Wintges K; Marshall RP; Mautner A; Duchstein L; Otto B; Horst AK; Amling M; Kreienkamp HJ; Schinke T J Immunol; 2015 Oct; 195(8):3675-84. PubMed ID: 26363054 [TBL] [Abstract][Full Text] [Related]
10. Therapeutic interventions in mice with chronic proliferative dermatitis (cpdm/cpdm). Gijbels MJ; Elliott GR; HogenEsch H; Zurcher C; van den Hoven A; Bruijnzeel PL Exp Dermatol; 2000 Oct; 9(5):351-8. PubMed ID: 11016856 [TBL] [Abstract][Full Text] [Related]
11. Integrin beta 1 inhibition alleviates the chronic hyperproliferative dermatitis phenotype of SHARPIN-deficient mice. Peuhu E; Salomaa SI; De Franceschi N; Potter CS; Sundberg JP; Pouwels J PLoS One; 2017; 12(10):e0186628. PubMed ID: 29040328 [TBL] [Abstract][Full Text] [Related]
12. IFN-gamma is necessary but not sufficient for anti-CD40 antibody-mediated inhibition of the Th2 response to Schistosoma mansoni eggs. Martin DL; King CL; Pearlman E; Strine E; Heinzel FP J Immunol; 2000 Jan; 164(2):779-85. PubMed ID: 10623823 [TBL] [Abstract][Full Text] [Related]
13. Interleukin-12 enhances contact hypersensitivity by modulating the in vivo cytokine pattern in mice. Xu B; Aoyama K; Kitani A; Yu S; Matsuyama T; Matsushita T J Interferon Cytokine Res; 1998 Jan; 18(1):23-31. PubMed ID: 9475664 [TBL] [Abstract][Full Text] [Related]
17. The Inflammatory Caspases-1 and -11 Mediate the Pathogenesis of Dermatitis in Sharpin-Deficient Mice. Douglas T; Champagne C; Morizot A; Lapointe JM; Saleh M J Immunol; 2015 Sep; 195(5):2365-73. PubMed ID: 26216893 [TBL] [Abstract][Full Text] [Related]
18. IL-4 promotes airway eosinophilia by suppressing IFN-gamma production: defining a novel role for IFN-gamma in the regulation of allergic airway inflammation. Cohn L; Herrick C; Niu N; Homer R; Bottomly K J Immunol; 2001 Feb; 166(4):2760-7. PubMed ID: 11160342 [TBL] [Abstract][Full Text] [Related]
19. Changes in keratin and filaggrin expression in the skin of chronic proliferative dermatitis (cpdm) mutant mice. HogenEsch H; Boggess D; Sundberg JP Pathobiology; 1999; 67(1):45-50. PubMed ID: 9873228 [TBL] [Abstract][Full Text] [Related]
20. IFN-gamma-inducing factor (IL-18) increases allergic sensitization, serum IgE, Th2 cytokines, and airway eosinophilia in a mouse model of allergic asthma. Wild JS; Sigounas A; Sur N; Siddiqui MS; Alam R; Kurimoto M; Sur S J Immunol; 2000 Mar; 164(5):2701-10. PubMed ID: 10679111 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]